The pharmaceutical industry has been in the spotlight during the past few years due to the pandemic as companies rushed to develop antiviral drugs and vaccines. Moreover, pharma stocks tend to be safe-haven investments during turbulent times.
So, I think it might be ideal to buy fundamentally robust Novo Nordisk A/S (NVO) and Novartis AG (NVS), which are poised to grow.
